Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Helius Medical Technologies, Inc. - Class A (HSDT)
NASDAQ:AMEX Investor Relations:
heliusmedical.com/index.php/investor-relations/overview
Company Research
Source: GlobeNewswire
-- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December 31, 2023. Fourth Quarter and Recent Business Updates Secured Healthcare Common Procedure Coding System (“HCPCS”) Level II codes for the Portable Neuromodulation Stimulator (“PoNS®”) mouthpiece and controller from the Centers for Medicare & Medicaid Services (“CMS”), representing a significant step toward reimbursement.Further expanded the registrational program in stroke by adding a second site and initiating an open-label study; reached alignment with the U.S. Food and Drug Administration (“FDA”) on optimizing the stroke development plan.Signed a letter of intent (“LOI”) with the Québec Ministry of Health and Social Services (“MS
Show less
Read more
Impact Snapshot
Event Time:
HSDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSDT alerts
High impacting Helius Medical Technologies, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
HSDT
News
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center [Yahoo! Finance]Yahoo! Finance
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterGlobeNewswire
- FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers [Seeking Alpha]Seeking Alpha
- Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ [Yahoo! Finance]Yahoo! Finance
HSDT
Earnings
- 3/28/24 - Beat
HSDT
Sec Filings
- 4/26/24 - Form S-1/A
- 4/15/24 - Form S-1
- 4/5/24 - Form 8-K
- HSDT's page on the SEC website